Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review

Overview of attention for article published in Respiratory Research, December 2011

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 47 Dimensions

Readers on

mendeley: 57 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,901 followers.

@Metal_Terium @_HeartofGrace_ @Free2TalknTrade EX1: VIP provides the combined potential advantages of lowering pulmonary arterial pressure, improving blood circulation to the heart and lung, reducing inflammation of the heart and lung tissues https://t.co

13 Aug 2022

Reply Repost Favourite

Great DD! Remdevisir is still expecting a $3b sales this year total. $RLFTF drug #zyesami data showed that it improves survival and decrease hospitalization for severe covid cases. $RLFTF a Swiss company, market cap is $0.7b can see double digits! FDA appr

11 Jul 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.